Link, Hartmut http://orcid.org/0000-0002-9659-0265
Kerkmann, Markus http://orcid.org/0000-0002-7151-5875
Holtmann, Laura http://orcid.org/0009-0009-5776-5614
Detzner, Markus
Funding for this research was provided by:
Pharmacosmos
Article History
Received: 21 June 2023
Accepted: 18 December 2023
First Online: 19 January 2024
Declarations
:
: An opinion has been obtained from the Ethics Committee of Rhineland-Palatinate, Mainz, Germany, in accordance with the guidelines and recommendations for ensuring Good Epidemiological Practice (GEP) [CitationRef removed]. Due to the nature of the study, no additional opinions from ethics committees were required. All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
: Not applicable.
: Not applicable.
: Hartmut Link: funding Pharmacosmos, institutional, research grant to German Cancer Society; Teva, research grant; financial interests, speaker and consultant honoraria Pharmacosmos, Teva. Markus Detzner, Laura Holtmann, and Markus Kerkmann have no interests to declare that are relevant to the content of this article.
: The funding source did not have any access to the data and was not involved in data analysis or manuscript writing.
: The guidelines for Observational Studies in Epidemiology (STROBE) were taken into account as far as applicable [CitationRef removed].